chr12-49587685-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032130.3(FAM186B):āc.2602A>Gā(p.Lys868Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,613,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032130.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM186B | NM_032130.3 | c.2602A>G | p.Lys868Glu | missense_variant | 7/7 | ENST00000257894.2 | NP_115506.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM186B | ENST00000257894.2 | c.2602A>G | p.Lys868Glu | missense_variant | 7/7 | 1 | NM_032130.3 | ENSP00000257894.2 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251288Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135834
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.000175 AC XY: 127AN XY: 727238
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2024 | The c.2602A>G (p.K868E) alteration is located in exon 7 (coding exon 7) of the FAM186B gene. This alteration results from a A to G substitution at nucleotide position 2602, causing the lysine (K) at amino acid position 868 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at